FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

19868411000001101: Matever 500mg tablets (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Feb 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
67073401000001118 Matever 500mg tablets (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
67073501000001119 Matever 500mg tablets (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Matever 500mg tablets (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Matever 500mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Matever 500mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Matever 500mg tablets (Aspire Pharma Ltd) Is a Product containing precisely levetiracetam 500 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Matever 500mg tablets (Aspire Pharma Ltd) Has active ingredient Levetiracetam false Inferred relationship Existential restriction modifier
Matever 500mg tablets (Aspire Pharma Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Matever 500mg tablets (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Matever 500mg tablets (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Matever 500mg tablets (Aspire Pharma Ltd) Has specific active ingredient Levetiracetam true Inferred relationship Existential restriction modifier
Matever 500mg tablets (Aspire Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Matever 500mg tablets (Aspire Pharma Ltd) Has excipient Sorbic acid false Inferred relationship Existential restriction modifier
Matever 500mg tablets (Aspire Pharma Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Matever 500mg tablets (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Matever 500mg tablets (Aspire Pharma Ltd) Is a Matever true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Matever 500mg tablets (Aspire Pharma Ltd) 60 tablet 6 x 10 tablets Has AMP True Matever 500mg tablets (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start